Bull Flag Stocks
1SXP.DE is forming a bull flag pattern, suggesting a potential continuation of its upward trend.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Price & Overview
FRA:1SXP • DE000A3ENQ51
Current stock price
14.88 EUR
-0.32 (-2.11%)
Last:
The current stock price of 1SXP.DE is 14.88 EUR. Today 1SXP.DE is down by -2.11%. In the past month the price increased by 10.22%. In the past year, price decreased by -37.22%.
1SXP.DE Key Statistics
52-Week Range12.62 - 30.25
Current 1SXP.DE stock price positioned within its 52-week range.
1-Month Range13.1 - 15.72
Current 1SXP.DE stock price positioned within its 1-month range.
- Market Cap
- 2.241B
- P/E
- 14.88
- Fwd P/E
- 13.64
- EPS (TTM)
- 1.00
- Dividend Yield
- 1.21%
1SXP.DE Stock Performance
Today
-2.11%
1 Week
-4.74%
1 Month
+10.22%
3 Months
-0.93%
Longer-term
6 Months -25.60%
1 Year -37.22%
2 Years -62.16%
3 Years N/A
5 Years N/A
10 Years N/A
1SXP.DE Stock Chart
1SXP.DE Stock Screens
1SXP.DE currently appears in the following ChartMill screener lists.
1SXP.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1SXP.DE. When comparing the yearly performance of all stocks, 1SXP.DE is a bad performer in the overall market: 90.99% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
1SXP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. 1SXP.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1SXP.DE Earnings
On February 11, 2026 1SXP.DE reported an EPS of 0.22 and a revenue of 240.19M. The company beat EPS expectations (14.88% surprise) and beat revenue expectations (2.64% surprise).
Next Earnings DateMay 13, 2026
Last Earnings DateFeb 11, 2026
PeriodQ1 / 2026
EPS Reported€0.22
Revenue Reported240.188M
EPS Surprise 14.88%
Revenue Surprise 2.64%
1SXP.DE Forecast & Estimates
19 analysts have analysed 1SXP.DE and the average price target is 19.93 EUR. This implies a price increase of 33.93% is expected in the next year compared to the current price of 14.88.
For the next year, analysts expect an EPS growth of -1.71% and a revenue growth 2.39% for 1SXP.DE
Analysts
Analysts76.84
Price Target19.93 (33.94%)
EPS Next Y-1.71%
Revenue Next Year2.39%
1SXP.DE Groups
Sector & Classification
1SXP.DE Financial Highlights
Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 1. The EPS increased by 12.36% compared to the year before.
Income Statements
Revenue(TTM)996.56M
Net Income(TTM)150.74M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.13% | ||
| ROA | 9.26% | ||
| ROE | 16.21% | ||
| Debt/Equity | 0.08 |
Chartmill High Growth Momentum
EPS Q2Q%15.79%
Sales Q2Q%4.5%
EPS 1Y (TTM)12.36%
Revenue 1Y (TTM)4.39%
1SXP.DE Ownership
Ownership
Inst Owners21.46%
Shares150.61M
Float34.64M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
1SXP.DE Competitors/Peers
The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 56S1 | SARTORIUS STEDIM BIOTECH | 36.16 | 18.123B | ||
| SRT3 | SARTORIUS AG-VORZUG | 38.11 | 16.092B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 31.52 | 15.368B | ||
| SRT | SARTORIUS AG | 26.11 | 12.46B | ||
| QIA | QIAGEN N.V. | 14.63 | 6.706B | ||
| EVT | EVOTEC SE | N/A | 960.552M | ||
| GXI | GERRESHEIMER AG | 8.87 | 777.15M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 15.04 | 205.599M | ||
| MLC | MALIN CORP PLC | N/A |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1SXP.DE
Company Profile
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
Company Info
IPO: 2023-09-28
SCHOTT PHARMA AG& CO KGAA
Hattenbergstrasse 10
MAINZ HESSEN DE
Employees: 4829
Phone: 496131660
SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ
Can you describe the business of SCHOTT PHARMA AG& CO KGAA?
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
What is the current price of 1SXP stock?
The current stock price of 1SXP.DE is 14.88 EUR. The price decreased by -2.11% in the last trading session.
What is the dividend status of SCHOTT PHARMA AG& CO KGAA?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 1.21%. The yearly dividend amount is currently 0.16.
How is the ChartMill rating for SCHOTT PHARMA AG& CO KGAA?
1SXP.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is SCHOTT PHARMA AG& CO KGAA worth?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a market capitalization of 2.24B EUR. This makes 1SXP.DE a Mid Cap stock.
What is the next earnings date for 1SXP stock?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) will report earnings on 2026-05-13.